RxDoctor Payments Data

Nigel Hogan, DO

Family Medicine · Paulding, OHNPI 1194110775

Payments from drug & device makers

$625in general payments, 2019–2025

Across 45 payments — averaging $13.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$290
  • Novo Nordisk$56
  • Amgen$51
  • Exact Sciences$45
  • Astellas Pharma US Inc$34
  • AstraZeneca$32
  • plus $117 from 6 others

What the payments were for

  • Food & beverage$625100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$625 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$118,734
Medicare patients
247
Services billed
2,254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide65$142,690
OzempicSemaglutide77$133,363
TrulicityDulaglutide61$117,702
EliquisApixaban59$95,779
JardianceEmpagliflozin46$74,350
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$28,042
RybelsusSemaglutide13$24,097
UbrelvyUbrogepant11$14,279
Tiotropium Bromide20$8,015
Lantus SolostarInsulin Glargine,hum.Rec.Anlog47$5,899
SuboxoneBuprenorphine Hcl/Naloxone Hcl12$4,919
Metoprolol Succinate223$4,829
Atorvastatin Calcium477$4,052
Gabapentin126$3,818
Levothyroxine Sodium202$2,481

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$16$260,392126 claims
Novo NordiskOzempic, Rybelsus$56$157,46090 claims
PfizerEliquis$27$95,77959 claims
GSKTrelegy Ellipta$14$28,04220 claims
AbbVieUbrelvy, Synthroid$290$15,80099 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Paulding

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →